Cytosorbents Corporation CTSO
4.38
0.08
1.86%
as of 25 Sep
- Market cap
- $13.6M
- P/E
- 0.0×
Follow CTSO
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.05 | 0.07 | 0.08 | 0.11 | 0.21 | 0.38 | 0.25 | 0.55 | 0.60 | 0.75 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(0.41) | (1.06) | (0.37) | (0.74) | (1.65) | (14.62) | (1.51) | (4.58) | (22.08) | (6.66) |
P/B ratio |
0.34 | 0.22 | 0.10 | 0.11 | 0.15 | 0.20 | 1.82 | 0.73 | 0.88 | 5.37 |
Price to Tangible BV |
0.74 | 0.34 | 0.13 | 0.13 | 0.16 | 0.21 | 109.51 | 0.73 | 0.88 | 5.37 |
EV/Sales |
0.40 | 0.30 | (0.22) | (0.38) | (0.68) | (1.34) | 0.36 | 0.00 | 0.11 | 0.72 |
EV/EBITDA |
0.00 | 0.00 | 0.22 | 0.43 | 1.35 | 5.85 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.20) | (0.74) | 0.31 | 0.46 | 2.09 | 9.78 | (0.54) | 0.00 | (0.27) | (1.02) |
EV/FCF |
(1.17) | (0.71) | 0.30 | 0.38 | 1.60 | 7.53 | (0.49) | 0.00 | (0.21) | (0.94) |
Quick Ratio |
1.42 | 1.59 | 1.44 | 2.86 | 4.14 | 7.54 | 1.68 | 3.80 | 2.49 | 1.56 |
Current Ratio |
2.13 | 2.20 | 1.81 | 3.48 | 4.70 | 8.12 | 2.10 | 4.09 | 2.64 | 1.83 |
Net Debt/EBITDA |
(0.85) | (0.40) | 0.30 | 0.56 | 1.77 | 7.50 | (0.15) | 0.82 | 0.77 | 0.03 |
Debt/Assets |
37.72% | 29.54% | 9.52% | 8.08% | 15.44% | 1.14% | 54.97% | 29.07% | 41.46% | 50.67% |
Debt/Equity |
2.82 | 1.26 | 0.21 | 0.14 | 0.22 | 0.01 | 4.40 | 0.59 | 0.97 | 3.67 |
Asset Turnover |
0.81 | 0.71 | 0.54 | 0.45 | 0.48 | 0.70 | 0.81 | 0.77 | 0.90 | 0.91 |
Operating CF/Net income |
1.51 | 0.70 | 0.74 | 0.86 | 0.57 | 0.72 | 0.87 | 0.63 | 0.73 | 0.57 |
Capex/Depreciation |
(0.17) | (0.31) | (0.46) | (5.70) | (3.79) | (1.70) | (2.18) | (3.12) | (5.59) | (3.10) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (96.39%) | (119.80%) | (99.38%) | (67.00%) | (34.64%) | (18.97%) | (189.32%) | (126.57%) | (151.66%) | (246.41%) | |
| (17.91%) | (41.30%) | (50.34%) | (42.96%) | (27.37%) | (13.36%) | (62.57%) | (59.04%) | (52.05%) | (112.31%) | |
ROIC |
(56.48%) | (61.12%) | (138.73%) | (107.43%) | (58.59%) | (73.46%) | (190.11%) | (216.12%) | (209.74%) | (715.47%) |
Return on Tangible Assets |
(43.73%) | (99.70%) | (136.54%) | (94.32%) | (44.04%) | (10.53%) | (149.46%) | (74.58%) | (61.54%) | (285.54%) |
Average Days of Receivables |
74.35 | 75.06 | 71.12 | 59.61 | 38.25 | 45.93 | 65.35 | 63.95 | 53.14 | 54.92 |
Research and Development Expense of Revenue |
13.72% | 21.37% | 50.17% | 43.58% | 37.95% | 21.49% | 48.47% | 34.32% | 21.26% | 42.75% |
Selling, General and Administrative Expense of Revenue |
96.17% | 94.77% | 123.23% | 98.84% | 82.82% | 69.42% | 88.20% | 92.76% | 98.44% | 123.94% |
Intangible Assets out of Total Assets |
0.07 | 0.08 | 0.00 | 0.07 | 0.05 | 0.05 | 0.12 | 0.08 | 0.08 | 0.12 |
Share Based Compensation of Revenue |
7.46% | 10.56% | 13.37% | 10.95% | 14.37% | 11.48% | 11.38% | 23.93% | 26.43% | 33.46% |
Graham Net Nets |
(8.86) | (5.92) | (1.71) | 1.49 | 4.11 | 4.64 | (0.49) | 0.89 | 0.76 | (0.07) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(406.25%) | (835.16%) | (1,196.26%) | (832.23%) | (272.08%) | (50.19%) | (311.69%) | (138.61%) | (92.23%) | (157.87%) |
Free Cash Flow Yield |
(642.35%) | (609.55%) | (945.60%) | (874.85%) | (201.31%) | (47.12%) | (294.38%) | (99.59%) | (90.00%) | (101.97%) |
Revenue per Share |
11.91 | 13.08 | 13.92 | 15.92 | 19.91 | 21.13 | 15.47 | 14.65 | 10.97 | 7.49 |
Operating CF per Share |
(3.98) | (5.30) | (9.70) | (12.96) | (6.46) | (2.89) | (10.39) | (7.06) | (4.68) | (5.29) |
Capex per Share |
(0.13) | (0.25) | (0.42) | (2.96) | (1.97) | (0.86) | (0.94) | (0.99) | (1.22) | (0.47) |
Free Cash Flow per Share |
(4.11) | (5.55) | (10.12) | (15.92) | (8.43) | (3.76) | (11.33) | (8.05) | (5.89) | (5.76) |
Cash per Share |
2.01 | 3.04 | 6.33 | 10.16 | 24.05 | 36.80 | 7.58 | 14.56 | 12.55 | 4.12 |
Shareholders Equity per Share |
1.90 | 4.08 | 10.52 | 16.24 | 28.86 | 40.81 | 2.12 | 11.03 | 7.43 | 1.05 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.90 | 4.08 | 10.52 | 16.24 | 28.86 | 40.81 | 2.12 | 11.03 | 7.43 | 1.05 |
Free Cash Flow |
(12.79) | (15.10) | (22.59) | (34.69) | (18.29) | (7.29) | (18.28) | (12.36) | (8.14) | (7.33) |
Working Capital |
10.93 | 11.78 | 11.36 | 24.05 | 50.61 | 72.30 | 10.97 | 21.35 | 12.89 | 3.55 |
Capital Expenditures |
(0.41) | (0.67) | (0.94) | (6.46) | (4.28) | (1.68) | (1.52) | (1.52) | (1.68) | (0.60) |
Net Current Asset Value |
(17.64) | (14.66) | (4.08) | 5.90 | 37.36 | 71.72 | (3.06) | 11.00 | 6.90 | (0.53) |
EV/EBIT |
0.00 | 0.00 | 0.21 | 0.41 | 1.29 | 5.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.02 | 0.03 | 0.19 | 0.10 | 0.04 | 0.06 | 0.07 | 0.11 | 0.06 |
Net Profit Margin |
(22.12%) | (58.21%) | (94.09%) | (94.59%) | (56.89%) | (19.11%) | (77.22%) | (76.48%) | (58.06%) | (123.47%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.31 | 0.24 | 0.20 | 0.11 | 0.22 | 0.46 | 0.36 | 0.28 | 0.21 | 0.34 |
Cash ROIC |
(70.09%) | (70.19%) | (74.34%) | (62.24%) | (14.90%) | (5.10%) | (60.86%) | (25.52%) | (20.93%) | (63.51%) |
Accounts Receivable Turnover |
4.98 | 5.32 | 5.30 | 6.81 | 8.92 | 8.52 | 5.93 | 7.32 | 8.33 | 9.15 |
Accounts Payable Turnover |
3.41 | 3.00 | 3.35 | 6.26 | 4.76 | 5.71 | 4.18 | 5.49 | 4.29 | 3.92 |
Inventory Turnover |
2.64 | 3.51 | 2.67 | 3.39 | 2.97 | 4.62 | 5.00 | 9.20 | 6.77 | 3.91 |
Average Days of Payables |
99.05 | 113.85 | 151.98 | 43.29 | 92.68 | 60.60 | 101.08 | 72.41 | 82.31 | 122.79 |
Days of Inventory on Hand |
182.33 | 93.16 | 134.93 | 90.53 | 157.47 | 88.30 | 104.78 | 40.60 | 52.63 | 76.99 |
Average Receivables |
7.44 | 6.69 | 5.86 | 5.09 | 4.84 | 4.81 | 4.21 | 3.07 | 1.82 | 1.04 |
Average Payables |
3.10 | 3.57 | 2.73 | 2.23 | 2.32 | 1.94 | 1.76 | 1.37 | 1.29 | 1.01 |
Average Inventory |
4.01 | 3.05 | 3.42 | 4.11 | 3.72 | 2.39 | 1.47 | 0.81 | 0.81 | 1.01 |
Average Assets |
45.78 | 50.16 | 58.09 | 76.38 | 89.73 | 58.67 | 30.79 | 29.15 | 16.90 | 10.47 |
Average Common Equity |
8.51 | 17.29 | 29.43 | 48.98 | 70.90 | 41.32 | 10.18 | 13.60 | 5.80 | 4.77 |
Columns are period end dates